Intech Investment Management LLC Grows Stock Holdings in CorVel Co. (NASDAQ:CRVL)

Intech Investment Management LLC grew its holdings in shares of CorVel Co. (NASDAQ:CRVL) by 136.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 20,196 shares of the business services provider’s stock after purchasing an additional 11,639 shares during the period. Intech Investment Management LLC’s holdings in CorVel were worth $2,247,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CRVL. Fifth Third Bancorp lifted its holdings in shares of CorVel by 45.9% during the fourth quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 101 shares during the last quarter. Jones Financial Companies Lllp bought a new stake in shares of CorVel during the fourth quarter valued at approximately $37,000. US Bancorp DE increased its position in shares of CorVel by 225.4% during the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 266 shares in the last quarter. GAMMA Investing LLC increased its position in shares of CorVel by 175.2% during the fourth quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock valued at $48,000 after acquiring an additional 275 shares in the last quarter. Finally, Exchange Traded Concepts LLC increased its position in shares of CorVel by 216.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 532 shares of the business services provider’s stock valued at $59,000 after acquiring an additional 364 shares in the last quarter. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of CorVel from a “buy” rating to a “hold” rating in a research report on Thursday, March 13th.

Insiders Place Their Bets

In other CorVel news, Director Steven J. Hamerslag sold 10,000 shares of CorVel stock in a transaction that occurred on Thursday, February 6th. The shares were sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the sale, the director now owns 314,000 shares of the company’s stock, valued at approximately $38,772,720. The trade was a 3.09 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jeffrey J. Michael sold 10,477 shares of CorVel stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $116.45, for a total transaction of $1,220,046.65. Following the completion of the sale, the director now directly owns 568,310 shares of the company’s stock, valued at approximately $66,179,699.50. This trade represents a 1.81 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 32,200 shares of company stock valued at $3,824,115. Company insiders own 47.57% of the company’s stock.

CorVel Stock Down 0.9 %

Shares of CRVL opened at $107.32 on Friday. The company has a market capitalization of $5.51 billion, a P/E ratio of 63.13 and a beta of 1.06. The firm has a 50 day moving average of $112.02 and a 200 day moving average of $114.11. CorVel Co. has a twelve month low of $76.20 and a twelve month high of $128.61.

CorVel (NASDAQ:CRVL) last posted its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.